Status:
UNKNOWN
Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?
Lead Sponsor:
University Hospital Birmingham
Collaborating Sponsors:
British Heart Foundation
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The investigators have previously demonstrated that the administration of insulin in the form of an infusion with additional sugar and potassium may improve cardiovascular performance and reduce bioch...
Eligibility Criteria
Inclusion
- Type II diabetes mellitus patients (as defined by WHO)
- Diet, oral hypoglycaemic or insulin therapy
- Undergoing elective and urgent coronary artery bypass surgery
Exclusion
- Non-diabetics
- Emergency and redo CABG
- \< 18 years
- Pregnancy
- Dialysis-dependence
- History of CVA/TIA \< 6 months
- Heart valve disease requiring surgery
- STEMI \< 3 months
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00899483
Start Date
July 1 2009
Last Update
May 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Birmingham
Birmingham, West Midlands, United Kingdom, B15 2TH